Coronary Sinus Reducing Stent for the Treatment of Refractory Angina Pectoris: A Health Technology Assessment.
Michal StanakEleen RothschedlPiotr SzymańskiPublished in: Medical devices (Auckland, N.Z.) (2020)
Even though the current evidence indicates that the assessed technology, CSRS, is potentially more effective than sham intervention for refractory AP patients, the lack of internal validity of the studies undermines the partially positive results.
Keyphrases
- coronary artery disease
- end stage renal disease
- coronary artery
- public health
- ejection fraction
- healthcare
- newly diagnosed
- randomized controlled trial
- chronic kidney disease
- prognostic factors
- mental health
- transcription factor
- peritoneal dialysis
- clinical trial
- health information
- percutaneous coronary intervention
- heart failure
- climate change
- patient reported outcomes
- transcatheter aortic valve replacement
- replacement therapy